Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Oncogenic potential of Hsp72

Abstract

Hsp72 is the major heat shock-inducible protein capable of protecting cells from a variety of stresses. In non-transformed cells at normal conditions Hsp72 is expressed at very low levels. It is, however, present at elevated levels in the major fraction of tumors and in many transformed cell lines. It is commonly assumed that in tumor cells the expression of Hsp72 at elevated levels is the consequence of oncogenic transformation. In the present study we addressed an alternative possibility that Hsp72 plays an active role in the process of oncogenic transformation. We report here that when Hsp72 was expressed in the Rat-1 fibroblasts either constitutively or from an adenovirus-based construct, cells become oncogenically transformed by the following criteria: loss of contact inhibition and formation of foci characteristic for oncogenically transformed cells; acquisition of the ability to grow in an anchorage-independent manner and to form colonies in soft agar; generation of tumors upon injection into mice. Furthermore, we also report that turning off the Hsp72 expression led to the reversal of the transformed phenotype. We also show that oncogenic potential of Hsp72 is confined in its peptide binding domain since the expression of this domain alone was sufficient for oncogenic transformation of Rat-1 cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 5
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Amici C, Palamara A and Santoro M. . 1993 Exp. Cell Res. 207: 230–234.

  • Ciocca D, Clark G, Tandon A, Fuqua S, Welch W and McGuire WJ. . 1993 Natl. Cancer Inst. 85: 570–574.

  • Clark G, Cox A, Graham S and Der C. . 1995 Methods in Enzymology 225: 395–412.

  • Feder J, Rossi J, Solomon J, Solomon N and Lindquist S. . 1992 Genes and Devel. 6: 1402–1413.

  • Gabai V, Meriin A, Mosser D, Caron A, Rits S, Shifrin V and Sherman M. . 1997 J. Biol. Chem. 272: 18033–18037.

    Article  CAS  Google Scholar 

  • Georgopoulos C and Welch W. . 1993 Annu. Rev. Cell Biol. 9: 601–634.

  • Heydari A, Takahashi R, Gutsmann A, You S and Richardson A. . 1994 Experientia 50: 1092–1098.

    Article  CAS  Google Scholar 

  • Jani A, Lochmuller H, Acsadi G, Simoneau M, Huard J, Garnier A, Karpati G and Massie B. . 1997 J. Virol. Methods 64: 111–124.

  • Li G, Li L, Liu R, Pehman M and Lee W. . 1992 Proc.Natl. Acad. Sci. USA 89: 2036–2040.

  • Li G, Mivechi N and Weitzel G. . 1995 Int. J. Hyperthermia 11: 459–488.

  • Mosser DD, Caron AW, Bourget L, Denis-Larose C and Massie B. . 1997a Mol. Cell. Biol. 17: 5317–5327.

    Article  CAS  Google Scholar 

  • Mosser D, Caron A, Bourget L, Jolicoeur P and Massie B. . 1997b Biotechniques 22: 150–161.

    Article  CAS  Google Scholar 

  • Pratt W. . 1997 Ann. Rev. Pharmacol. Toxicol. 37: 297–326.

    Article  CAS  Google Scholar 

  • Rattan S. . 1996 Exp. Gerontol. 31: 33–47.

  • Seo J, Park Y, Kim J, Shim E, Kim C, Jang J, Kim S and Lee W. . 1996 Biochem. Biophys. Res. Commun. 218: 582–587.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Volloch, V., Sherman, M. Oncogenic potential of Hsp72. Oncogene 18, 3648–3651 (1999). https://doi.org/10.1038/sj.onc.1202525

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202525

Keywords

This article is cited by

Search

Quick links